Your browser doesn't support javascript.
loading
Fibroblast-derived LPP as a biomarker for treatment response and therapeutic target in gastric cancer.
Wang, Hao; Wu, Jing; Ling, Ruoyu; Li, Fengping; Yang, Qingbin; He, Jiayong; Lei, Xuetao; Wu, Chaorui; Zhang, Guofan; Zheng, Boyang; Peng, Yanmei; Zhang, Yihao; Chen, Hao; Ye, Gengtai; Li, Guoxin.
Afiliação
  • Wang H; Department of General Surgery, Nanfang Hospital, Southern Medical University, Guangdong Provincial Engineering Technology Research Center of Minimally Invasive Surgery, 1838 North Guangzhou Avenue, Guangzhou 510515, China.
  • Wu J; Guangdong Provincial Key Laboratory of Precision Medicine for Gastrointestinal Tumor, Guangzhou 510515, China.
  • Ling R; Department of General Surgery, Nanfang Hospital, Southern Medical University, Guangdong Provincial Engineering Technology Research Center of Minimally Invasive Surgery, 1838 North Guangzhou Avenue, Guangzhou 510515, China.
  • Li F; Guangdong Provincial Key Laboratory of Precision Medicine for Gastrointestinal Tumor, Guangzhou 510515, China.
  • Yang Q; Department of General Surgery, Nanfang Hospital, Southern Medical University, Guangdong Provincial Engineering Technology Research Center of Minimally Invasive Surgery, 1838 North Guangzhou Avenue, Guangzhou 510515, China.
  • He J; Guangdong Provincial Key Laboratory of Precision Medicine for Gastrointestinal Tumor, Guangzhou 510515, China.
  • Lei X; Department of General Surgery, Nanfang Hospital, Southern Medical University, Guangdong Provincial Engineering Technology Research Center of Minimally Invasive Surgery, 1838 North Guangzhou Avenue, Guangzhou 510515, China.
  • Wu C; Guangdong Provincial Key Laboratory of Precision Medicine for Gastrointestinal Tumor, Guangzhou 510515, China.
  • Zhang G; Department of General Surgery, Nanfang Hospital, Southern Medical University, Guangdong Provincial Engineering Technology Research Center of Minimally Invasive Surgery, 1838 North Guangzhou Avenue, Guangzhou 510515, China.
  • Zheng B; Guangdong Provincial Key Laboratory of Precision Medicine for Gastrointestinal Tumor, Guangzhou 510515, China.
  • Peng Y; Department of General Surgery, Nanfang Hospital, Southern Medical University, Guangdong Provincial Engineering Technology Research Center of Minimally Invasive Surgery, 1838 North Guangzhou Avenue, Guangzhou 510515, China.
  • Zhang Y; Guangdong Provincial Key Laboratory of Precision Medicine for Gastrointestinal Tumor, Guangzhou 510515, China.
  • Chen H; Department of General Surgery, Nanfang Hospital, Southern Medical University, Guangdong Provincial Engineering Technology Research Center of Minimally Invasive Surgery, 1838 North Guangzhou Avenue, Guangzhou 510515, China.
  • Ye G; Guangdong Provincial Key Laboratory of Precision Medicine for Gastrointestinal Tumor, Guangzhou 510515, China.
  • Li G; Department of General Surgery, Nanfang Hospital, Southern Medical University, Guangdong Provincial Engineering Technology Research Center of Minimally Invasive Surgery, 1838 North Guangzhou Avenue, Guangzhou 510515, China.
Mol Ther Oncolytics ; 24: 547-560, 2022 Mar 17.
Article em En | MEDLINE | ID: mdl-35229032
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Mol Ther Oncolytics Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Mol Ther Oncolytics Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China País de publicação: Estados Unidos